CCL22 and colon adenocarcinoma: To explore whether CCL22 was also associated with immune checkpoint therapy in COAD, the correlations between CCL22 and immune checkpoint molecules were analyzed (Kim et al., 2017; Nishino et al., 2017; Zhai et al., 2018).